TIN816
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for TIN816, covering 2025-05-01 to 2026-04-13. Get the full timeline:
Most recent: Clinical Trial Update: Phase 2b Study to Investigate the Safety and Efficacy of TIN816 in Sepsis-associated Acute Kidney Injury (CLEAR-AKI) [Phase 2]